Her2 amplification distinguishes a subset of non-muscle-invasive bladder cancers with a high risk of progression

Abstract

BackgroundSeveral studies have employed immunohistochemistry to detect Her2/neu overexpression in urothelial carcinomas, yielding a tremendous range of positive expression rates. Few studies have examined Her2 status in non-muscle invasive bladder...